Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 CHF | +0.12% | -1.10% | +14.16% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.16% | 529M | |
+1.94% | 42.59B | |
+7.87% | 40.65B | |
+49.22% | 40.57B | |
-11.96% | 26.77B | |
+9.42% | 24.81B | |
-24.34% | 18.17B | |
+27.16% | 12.05B | |
-3.22% | 11.7B | |
+6.86% | 11.1B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea to Sell Preclinical Oncology Program to Nodus Oncology in $248 Million Deal